Nurix Therapeutics, Inc. NRIX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Nurix Therapeutics, Inc. (NRIX) reported operating lease right-of-use assets in other assets of $51.66M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Nurix Therapeutics, Inc.'s operating lease right-of-use assets in other assets increased by 96.0% year-over-year, from $26.36M to $51.66M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 30.5% compound annual growth rate (CAGR), from $13.34M to $50.52M.